THE 3’ END PROTHROMBIN GENE VARIANTS IN SERBIAN PATIENTS WITH IDIOPATHIC THROMBOPHILIA
Aradjanski M1, Djordjevic V1, Pruner I1,*, Tomic B1, Gvozdenov M1, Kovac M2,3, Radojkovic D1
*Corresponding Author: Dr. Iva Pruner, Institute of Molecular Genetics and Genetic Engineering, Vojvode Stepe 444A, PO Box 23, 11010 Belgrade, Serbia. Tel: +381-11-397-6658. Fax: +381-11-397-5808. E-mail: iva.pruner@ gmail.com
page: 43

REFERENCES

1. Colman RW, Clowes AW, George JN, Goldhaber SZ, Marder VJ. Overview of hemostasis. In: Colman RW, Marder VJ, Clowes AW, George JN, Goldhaber SZ. Haemostasis and Thrombosis: Basic Principles and Clinical Practice, 5th ed. Philadelphia, PA: Lippincott Wiliams & Wilkins. 2006: 2-15. 2. White RH. The epidemiology of venous thromboembolism. Circulation. 2003; 107(23 Suppl 1): 14-18. 3. Rosendaal FR. Venous thrombosis: Prevalence and interaction of risk factors. Haemostasis. 1999; (Suppl S1): S1-S9. 4. Griffin JH, Evatt B, Wideman C. Anticoagulant protein C pathway defective in majority of thrombophilia patients. Blood. 1993; 82(7): 1989-1993. 5. Egeberg O. Inherited antithrombin III deficiency causing thrombophilia. Thromb Diath Haemorrh. 1965; 13: 516-530. 6. Griffin JH, Evatt B, Zimmerman TS, Kleiss AJ, Wideman C. Deficiency of protrombin C in congenital thrombotic disease. J Clin Invest. 1981; 68(5): 1370-1373. 7. Comp PC, Nixon RR, Cooper MR, Esmon CT. Familial protein S deficiency is associated with recurrent thrombosis. J Clin Invest. 1984; 74(6): 2082-2088. 8. Cushman M. Inherited risk factors for venous thrombosis. Hematology Am Soc Hematol Educ Program 2005: 452-457. 9. März W, Nauck M, Wieland H. The molecular mechanisms of inherited thrombophilia. Z Kardiol. 2000; 89(7): 575-586. 10. Kalafatis M, Rand MD, Mann KG. The mechanism of inactivation of human factor V and human factor Va by activated protein C. J Biol Chem. 1994; 269(50): 31869-318680. 11. Bertina RM, Koeleman BPC, Koster T, Rosendaal FR, Dirven RJ, de Ronde H, et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature. 1994; 369(6475): 64-66. 12. De Stefano V, Chiusolo P, Paciaroni K, Leone G. Epidemiology of factor V Leiden: Clinical implications. Semin Thromb Hemost. 1998; 24(4): 367-379. 13. Gehring NH, Frede U, Neu-Yilik G, Hundsdoerfer P, Vetter B, Hentze MW, et al. Increased efficiency of mRNA 3’ end formation: a new genetic mechanism contributing to hereditary thrombophilia. Nat Genet. 2001; 28(4): 389-392. 14. Danckwardt S, Hentze MW, Kulozik AE. 3’ End mRNA processing: Molecular mechanisms and implications for health and disease. EMBO J. 2008; 27(3): 482-498. 15. Danckwardt S, Gehring NH, Neu-Yilik G, Hundsdoerfer P, Pforsich M, Frede U, et al. The prothrombin 3’ end formation signal reveals a unique architecture that is sensitive to thrombophilic gain-of-function mutations. Blood. 2004; 104(2): 428-435. 16. Danckwardt S, Hartmann K, Gehring NH, Hentze MW, Kulozik AE. 3’ End processing of the prothrombin mRNA in thrombophilia. Acta Haematol. 2006; 115(3-4): 192-197. 17. Flaujac C, Conard J, Horellou MH, Le Flem L, Samama MM. Atypical mutations of the prothrombin gene at positions 20,209 and 20,218, and a novel mutation at position 20,219. Report on 10 patients. J Thromb Haemost. 2007; 5(5): 1064-1068. 18. Warshawsky I, Hren C, Sercia L, Shadrach B, Deitcher SR, Newton E, et al. Detection of a novel point mutation of the prothrombin gene at position 20209. Diagn Mol Pathol. 2002; 11(3): 152-156. 19. Hooper C, Roberts S, Dowling N, Austin H, Lally C, Whitsett C. The prevalence of the prothrombin gene variant C20209T in African- Americans and Caucasians and lack of association with venous thromboembolism. Thromb Res. 2006; 118(6): 767-768. 20. Ceelie H, Bertina RM, van HylckamaVlieg A, Rosendaal FR, Vos HL. Polymorphisms in the prothrom-bin gene and their association with plasma prothrombin levels. Thromb Haemost. 2001; 85(6): 1066-1070. 21. Balim Z, Kosova B, Falzon K, Bezzina Wettinger S, Colak Y. Budd-Chiari syndrome in a patient heterozygous for the point mutation C20221T of the prothrombin gene. J Thromb Haemost. 2003; 1(4): 852-853. 22. Pérez-Ceballos E, Corral J, Alberca I, Vayá A, Llamas P, Montes R, et al. Prothrombin A19911G and G20210A polymorphisms’ role in thrombosis. J Haematol. 2002; 118(2): 610-614. 23. Martinelli I, Battaglioli T, Tosetto A, Legnani C, Sottile L, Ghiotto R, et al. Prothrombin A19911G polymorphism and the risk of venous thromboembolism. J Tromb Haemost. 2006; 4(12): 2582- 2586. 24. von Ahsen N, Oellerich M. The intronic prothrombin 19911A>G polymorphism influences splicing efficiency and modulates effects of the 20210G>A polymorphism on mRNA amount and expression in a stable reporter gene assay system. Blood. 2004; 103(2): 586-593. 25. Chinthammitr Y, Vos HL, Rosendaal FR, Doggen CJ. The association of prothrombin A19911G polymorphism with plasma prothrombin activity and venous thrombosis: results of the MEGA study, a large popula-tion-based case-control study. J Thromb Haemost. 2006; 4(12): 2587-2592. 26. Souto JC, Almasy L, Borrell M, Blanco-Vaca F, Mateo J, Soria JM, et al. Genetic susceptibility to thrombosis and its relationship to physiological risk factors: the GAIT study. Genetic analysis of idiopathic thrombophilia. Am J Hum Genet. 2000; 67(6): 1452-1459. 27. Djordjevic V, Pruner I, Kovac M, Miljic P, Antonijevic N, Kojic S, et al. Three novel 3’ end pro-thrombin gene polymorphisms and their association with thrombophilia (abstract). J Thromb Haemost. 2011; 9(Suppl 2): 873S.



Number 26
VOL. 26(1), 2023
Number 25
VOL. 25(2), 2022
Number 25
VOL. 25 (1), 2022
Number 24
VOL. 24(2), 2021
Number 24
VOL. 24(1), 2021
Number 23
VOL. 23(2), 2020
Number 22
VOL. 22(2), 2019
Number 22
VOL. 22(1), 2019
Number 22
VOL. 22, 2019 Supplement
Number 21
VOL. 21(2), 2018
Number 21
VOL. 21 (1), 2018
Number 21
VOL. 21, 2018 Supplement
Number 20
VOL. 20 (2), 2017
Number 20
VOL. 20 (1), 2017
Number 19
VOL. 19 (2), 2016
Number 19
VOL. 19 (1), 2016
Number 18
VOL. 18 (2), 2015
Number 18
VOL. 18 (1), 2015
Number 17
VOL. 17 (2), 2014
Number 17
VOL. 17 (1), 2014
Number 16
VOL. 16 (2), 2013
Number 16
VOL. 16 (1), 2013
Number 15
VOL. 15 (2), 2012
Number 15
VOL. 15, 2012 Supplement
Number 15
Vol. 15 (1), 2012
Number 14
14 - Vol. 14 (2), 2011
Number 14
The 9th Balkan Congress of Medical Genetics
Number 14
14 - Vol. 14 (1), 2011
Number 13
Vol. 13 (2), 2010
Number 13
Vol.13 (1), 2010
Number 12
Vol.12 (2), 2009
Number 12
Vol.12 (1), 2009
Number 11
Vol.11 (2),2008
Number 11
Vol.11 (1),2008
Number 10
Vol.10 (2), 2007
Number 10
10 (1),2007
Number 9
1&2, 2006
Number 9
3&4, 2006
Number 8
1&2, 2005
Number 8
3&4, 2004
Number 7
1&2, 2004
Number 6
3&4, 2003
Number 6
1&2, 2003
Number 5
3&4, 2002
Number 5
1&2, 2002
Number 4
Vol.3 (4), 2000
Number 4
Vol.2 (4), 1999
Number 4
Vol.1 (4), 1998
Number 4
3&4, 2001
Number 4
1&2, 2001
Number 3
Vol.3 (3), 2000
Number 3
Vol.2 (3), 1999
Number 3
Vol.1 (3), 1998
Number 2
Vol.3(2), 2000
Number 2
Vol.1 (2), 1998
Number 2
Vol.2 (2), 1999
Number 1
Vol.3 (1), 2000
Number 1
Vol.2 (1), 1999
Number 1
Vol.1 (1), 1998

 

 


 About the journal ::: Editorial ::: Subscription ::: Information for authors ::: Contact
 Copyright © Balkan Journal of Medical Genetics 2006